Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

InfaCare’s Jaundice Drug Stannsoporfin Brings Efficacy, Safety Questions Into US FDA Panel

May 03 2018

• By Sue Sutter

PS1805_JaudicedBaby_ 258511238 _1200.jpg

Related Content

Hyperbilirubinemia Drug Trials Should Target High-Risk Population

Jul 07 2003

Drugs For Severe Hyperbilirubinemia Could Face Long Development Program

Mar 19 2012

Mallinckrodt's InfaCare Buy Leaves Room For Further Diversifying M&A

Aug 07 2017

Related Companies

Mallinckrodt plc

Additional Topics

United States Advisory Committees Drug Review Pediatrics Regulation Liver & Hepatic BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window